Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $75.00 and last traded at $75.00, with a volume of 380 shares traded. The stock had previously closed at $71.20.
Wall Street Analysts Forecast Growth
Separately, Chardan Capital upgraded shares of Pharma Mar to a “strong-buy” rating in a research note on Thursday, August 1st.
Read Our Latest Analysis on PHMMF
Pharma Mar Price Performance
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Recommended Stories
- Five stocks we like better than Pharma Mar
- Insider Trades May Not Tell You What You Think
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- How to Calculate Return on Investment (ROI)
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
